Copyright
©The Author(s) 2024.
World J Clin Oncol. May 24, 2024; 15(5): 644-652
Published online May 24, 2024. doi: 10.5306/wjco.v15.i5.644
Published online May 24, 2024. doi: 10.5306/wjco.v15.i5.644
Table 1 Sociodemographic and clinical characteristics of patients, n (%)
Sociodemographic variables | Total, n = 182 |
Age, mean ± SD | 61.18 ± 13.32 |
Sex | |
Male | 79 (43.41) |
Female | 103 (56.59) |
Nationality | |
Lebanese | 173 (95.05) |
Other | 9 (4.95) |
Place of residency | |
City | 122 (67.03) |
Outside of the city | 60 (32.97) |
Work status | |
Worker | 63 (34.62) |
Non-worker | 119 (63.38) |
Educational level | |
Illiterate | 16 (8.79) |
Less than high school | 11 (6.04) |
High school | 25 (13.74) |
College | 35 (19.23) |
University | 95 (52.20) |
Status | |
Married | 142 (78.02) |
Single | 29 (15.93) |
Divorced | 1 (0.55) |
Widowed | 10 (5.50) |
Table 2 Characteristics of the patients’ households, n (%)
Characteristics | Total, n = 182 |
Total household income/month in USD | |
< 300 | 78 (42.86) |
Between 300 and 1000 | 56 (30.77) |
> 1000 | 48 (26.37) |
Number of people in household | 3.00 ± 1.54 |
Household members-excluding the patient-suffering from serious chronic disease | |
Yes | 62 (34.07) |
No | 120 (65.93) |
Table 3 Reasons for treatment disruption, n (%)
Characteristics | Value, n = 182 |
Stopped or interrupted any drugs including chemotherapy | |
Yes | 58 (31.87) |
Reason: | |
Shortage | 41 (70.69) |
Price/coverage | 8 (13.79) |
COVID-19 | 1 (1.72) |
Other | 8 (13.79) |
No | 124 (68.13) |
Changed any of their medications | |
Yes | 81 (44.51) |
Reason: | |
Shortage | 74 (91.36) |
Price | 3 (3.70) |
Coverage | 4 (4.94) |
No | 101 (55.49) |
Had a third-party payer | |
Yes | 160 (87.91) |
Syndicate | 4 (2.50) |
Insurance | 82 (51.25) |
CNSS | 52 (32.50) |
CFE | 4 (2.50) |
Ministry of Public Health | 13 (8.13) |
Army | 5 (3.12) |
No | 22 (12.09) |
Source of medication payment | |
Out-of-pocket | 87 (69.60) |
Donations | 14 (11.20) |
Family | 9 (7.20) |
Primary healthcare centers | 14 (11.20) |
Ministry of Public Health | 1 (0.80) |
Table 4 Financial coverage of the patient population, n (%)
Characteristics | Total, n = 182 |
Changing third-party payer due to coverage problems | |
Yes | 11 (6.04) |
No | 171 (93.96) |
Reporting financial difficulties due to health care spending | |
Yes | 144 (79.12) |
No | 38 (20.88) |
Self-medication instead of seeking medical treatment due to financial difficulties | |
Yes | 42 (23.08) |
No | 140 (76.92) |
Cancelled a treatment, surgery, or any procedure because of its cost during the last year | |
Yes | 25 (13.74)1 |
No | 157 (86.26) |
Suffering from other chronic diseases necessitating chronic treatments | |
Yes | 94 (51.65) |
No | 88 (48.35) |
Any problems accessing specific treatments for other chronic diseases | |
Yes | 76 (80.85) |
No | 18 (19.15) |
- Citation: Eid D, Jabbour J, Moujaes E, Kourie HR, Safieddine M, Kattan J. Impact of the economic crisis and drug shortage on Lebanese cancer patients’ care. World J Clin Oncol 2024; 15(5): 644-652
- URL: https://www.wjgnet.com/2218-4333/full/v15/i5/644.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i5.644